Private Equity

Shareholder Plantro Ltd. calls for the sale of Ag Growth International, citing poor performance and a flawed turnaround plan after a dismal Q4 report.

The 4th Annual Women of Influence Awards honored 18 trailblazers and raised major funds for Soul Reborn, a nonprofit empowering disadvantaged women.

GrafTech's major price increase on a key steelmaking component signals a market shift, putting new pressure on electric arc furnace steel producers.

Most business owners don't know how to sell. A new guide from an investment banker aims to change that with a practical, step-by-step playbook.

With a $2B war chest and a key simulation acquisition, Shield AI is accelerating the race to deploy AI pilots, reshaping the future of global defense.

With its 32nd straight dividend hike and a $100M buyback, Wiley leverages strong Q3 results and AI momentum to underscore its financial health.

With a new CFO experienced in major deals and a recent private equity infusion, MedSpeed is poised for aggressive expansion in healthcare logistics.

Pioneering period care brand Natracare rejects corporate buyouts, transitioning to an Employee Ownership Trust to permanently protect its ethical mission.

Zentro Internet's record-setting $240M financing is reshaping how niche ISPs grow, signaling strong investor confidence in digital infrastructure.

Australian giant Cobram Estate Olives acquires #1 US brand California Olive Ranch, creating a new global leader in the extra virgin olive oil market.

Real America's Voice expands with a Spanish-language channel, betting on free TV to deliver conservative content to a key demographic. But will it succeed?

After a turbulent year, Tidewater Renewables projects a major profit surge in 2026, fueled by operational fixes and powerful government support programs.

Lumexa Imaging posted strong 2025 revenue and cut its debt, yet a surprise net loss and EPS miss sent its stock tumbling. What's next for the imaging giant?

Amidst an energy crisis, DoGo Power launches its GFM Smart PV & ESS solution in South Africa, promising grid independence and lower costs for businesses.

With revenues up but losses widening, Arverne Group is aggressively investing in geothermal energy and lithium to secure France's energy independence.

Armata Pharmaceuticals posts a staggering $174M annual loss, triggering a 'going concern' alert, yet its promising phage therapy pipeline advances.

A major gold deal in Kyrgyzstan faces legal threats as international investors allege a lack of transparency and disregard for their rights in a pivotal sale.

Weave Bio forms a star-studded advisory board with leaders from Gilead and Takeda to navigate the high-stakes world of AI in drug development.

With a massive new debt facility, Budderfly is set to accelerate its no-cost energy upgrades for U.S. mid-market businesses, fueling a green transition.

The FDA has clarified its rules for desiccated thyroid extract (DTE), providing relief for patients and a new path forward for manufacturers like Acella.